Rockefeller Capital Management’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-29
Closed 2315
2022
Q4
$0 Buy
29
+19
+190% +$25 ﹤0.01% 3883
2022
Q3
$0 Hold
10
﹤0.01% 3932
2022
Q2
$0 Buy
+10
New +$27 ﹤0.01% 4125
2022
Q1
Sell
-4,053
Closed -$15K 3886
2021
Q4
$15K Sell
4,053
-4,510
-53% -$27.7K ﹤0.01% 2774
2021
Q3
$63K Buy
8,563
+3,762
+78% +$32.2K ﹤0.01% 2035
2021
Q2
$63K Buy
4,801
+3,551
+284% +$34.9K ﹤0.01% 1973
2021
Q1
$9K Buy
+1,250
New +$14.1K ﹤0.01% 2629
2020
Q4
Sell
-905
Closed -$11K 2863
2020
Q3
$11K Hold
905
﹤0.01% 1980
2020
Q2
$10K Buy
+905
New +$9.73K ﹤0.01% 1891

Other funds holding CLOV

Rockefeller Capital Management's CLOV Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Clover Health Investments (CLOV) in Q1 2023, closing a stake of 29 shares.

Rockefeller Capital Management first reported a position in CLOV in Q2 2020 and held it in 9 quarters. The position peaked at $63K in Q3 2021. 157 funds tracked by Wall St. Rank hold CLOV as of Q1 2023.

  • Rockefeller Capital Management reported no remaining Clover Health Investments position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 29 Clover Health Investments shares in Q1 2023.
  • Rockefeller Capital Management first reported a position in Clover Health Investments in Q2 2020 and held it in 9 quarters.
  • Rockefeller Capital Management's Clover Health Investments position peaked at $63K in Q3 2021.
  • 157 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.